Literature DB >> 16440071

Overweight and obesity-related metabolic disorders in hospital employees.

Lee-Ching Hwang1, Cheng-Ho Tsai, Tony Hsiu-Hsi Chen.   

Abstract

BACKGROUND: Obesity is associated with metabolic disorders and cardiovascular diseases. This study investigated the relationship between overweight and obese status and the incidence of type 2 diabetes, hypertension, hyperlipidemia and hyperuricemia.
METHODS: This prospective cohort study comprised 1749 hospital employees who received baseline health check-ups in 1993. Data from the 1027 participants (832 women, 195 men; mean age, 36 +/- 7 years) who repeated check-ups in 2003 were used in the analysis. Relative risks (RRs) for development of metabolic disorders during follow-up associated with different body mass index (BMI) categories at baseline as defined by Asia-Pacific recommendations and the Department of Health in Taiwan were calculated after adjustment for covariates.
RESULTS: The prevalence of overweight and obesity at baseline check-up were 17.6% and 14.5%, respectively. Obese subjects with baseline BMI >or= 25 kg/m2 had a significant multivariate-adjusted RR of 2.7 for hypertension, 14.8 for type 2 diabetes, 3.2 for hypertriglyceridemia, and 2.8 for hyperuricemia, compared to subjects with baseline BMI < 23.0 kg/m2. RR for diabetes was higher in women than in men, but RR for hypertriglyceridemia was higher in men. The risks of hypertension and hyperuricemia significantly increased for subjects with baseline BMI >or= 23 kg/m2, while RRs for type 2 diabetes increased significantly for baseline BMI >or= 24 kg/m2 and hypertriglyceridemia increased for baseline BMI >or= 25 kg/m2. The risks attributable to obesity (baseline BMI >or= 25 kg/m2) were 23.0% for hypertension, 70.8% for diabetes, 27.9% for hypertriglyceridemia, and 24.1% for hyperuricemia.
CONCLUSION: This study revealed that a high prevalence of overweight and obesity was associated with significantly increased risk of development of type 2 diabetes, hypertension, hypertriglyceridemia and hyperuricemia in hospital employees, suggesting the need for programs to improve weight management.

Entities:  

Mesh:

Year:  2006        PMID: 16440071     DOI: 10.1016/S0929-6646(09)60109-1

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  7 in total

1.  The role of uric acid in pediatric hypertension.

Authors:  Daniel I Feig; Richard J Johnson
Journal:  J Ren Nutr       Date:  2007-01       Impact factor: 3.655

Review 2.  The role of uric acid in the pathogenesis of hypertension in the young.

Authors:  Daniel I Feig
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-21       Impact factor: 3.738

3.  Morbidity associated with overweight and obesity in health personnel: a 10-year retrospective of hospital-based cohort study in Taiwan.

Authors:  Tzu-Lin Yeh; Hsin-Hao Chen; Hsiao-Hui Chiu; Yu-Hua Chiu; Lee-Ching Hwang; Shang-Liang Wu
Journal:  Diabetes Metab Syndr Obes       Date:  2019-03-07       Impact factor: 3.168

4.  Slightly increased BMI at young age is a risk factor for future hypertension in Japanese men.

Authors:  Yuki Someya; Yoshifumi Tamura; Yoshimitsu Kohmura; Kazuhiro Aoki; Sachio Kawai; Hiroyuki Daida
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

5.  A body mass index over 22 kg/m2 at college age is a risk factor for future diabetes in Japanese men.

Authors:  Yuki Someya; Yoshifumi Tamura; Yoshimitsu Kohmura; Kazuhiro Aoki; Sachio Kawai; Hiroyuki Daida; Hisashi Naito
Journal:  PLoS One       Date:  2019-01-24       Impact factor: 3.240

6.  Effects of diet versus diet plus aerobic and resistance exercise on metabolic syndrome in obese young men.

Authors:  Mohamed Ahmed Said; Mohamed Abdelmoneem; Mohamed Chaab Alibrahim; Moustafa Ahmed Elsebee; Ahmed Abdel Hamed Kotb
Journal:  J Exerc Sci Fit       Date:  2020-03-14       Impact factor: 3.103

7.  Prevalence, awareness and control of diabetes in the Seychelles and relationship with excess body weight.

Authors:  David Faeh; Julita William; Luc Tappy; Eric Ravussin; Pascal Bovet
Journal:  BMC Public Health       Date:  2007-07-19       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.